Thrivent Financial For Lutherans Editas Medicine, Inc. Transaction History
Thrivent Financial For Lutherans
- $52.6 Billion
- Q3 2024
A detailed history of Thrivent Financial For Lutherans transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 85,781 shares of EDIT stock, worth $228,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,781
Previous 85,781
-0.0%
Holding current value
$228,177
Previous $400,000
27.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EDIT
# of Institutions
248Shares Held
57MCall Options Held
410KPut Options Held
394K-
Black Rock Inc. New York, NY7.78MShares$20.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.68MShares$17.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$13 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$8.91 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$6.55 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $183M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...